Creating Value by Overcoming Treatment Barriers View previous quarters - Today Latest News View all press releases 09.29.26 Aquestive Therapeutics Strengthens Board of Directors with Appointment of Richard Daly Read More 09.17.26 Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm™ (dibutepinephrine) Sublingual Film Read More 09.01.26 Aquestive Therapeutics to Participate in Upcoming September Investor Conferences Read More Events View all events Upcoming Events There are no scheduled events at this time. Past Events 09.14.26 9:00 AM EDT H.C. Wainwright 28th Annual Global Investment Conference 09.09.26 3:20 PM EDT 2026 Cantor Global Healthcare Conference Fireside Chat Presentations View all presentations Corporate Presentation – September 2026 Anaphylm Human Factors and Clinical Study Supplemental Materials 1.7 MB Anaphylm™ (dibutepinephrine) Sublingual Film Complete Response Letter Supplemental Material 1.1 MB
09.29.26 Aquestive Therapeutics Strengthens Board of Directors with Appointment of Richard Daly Read More
09.17.26 Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm™ (dibutepinephrine) Sublingual Film Read More
